Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Cronos Australia Ltd. ( (AU:VIT) ) is now available.
Vitura Health Limited has announced that director Gerard Fogarty AO has ceased to be a director of the company as of 7 April 2026, with no securities held in his own name at the time of his departure. His indirect interest in the company is limited to 342,428 ordinary shares held by his spouse, Amanda Dorothy Fogarty, and there are no disclosed interests in any related contracts, indicating a relatively clean change in the company’s board composition with limited direct implications for its capital structure.
The notice formalises Fogarty’s exit under ASX listing rule 3.19A.3 and Corporations Act disclosure requirements, underscoring Vitura Health’s adherence to governance and transparency standards in reporting director interests. The change may prompt stakeholders to watch for future board appointments or strategic shifts, but the absence of complex shareholdings or contract ties suggests minimal immediate disruption to governance or shareholder alignment.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is an Australian listed company operating in the healthcare sector. The company’s securities are traded on the ASX, and its governance and director disclosures are reported in accordance with Australian corporate and listing rules.
Average Trading Volume: 354,637
Technical Sentiment Signal: Sell
Current Market Cap: A$25.18M
For an in-depth examination of VIT stock, go to TipRanks’ Overview page.